So, lorlatinib is a type of medicine called a third-generation ALK and ROS1 inhibitor. This med was made to zero in on and stop ALK and ROS1 kinases from doing their thing, which can make tumors grow in some lung cancer patients. And these patients have already tried other ALK inhibitors without luck.
There are two dosages for this drug; you’ve got 25 mg and 100 mg options, and both are tablets with that shiny coating. The advice is to take 100 mg of it every day, doesn’t matter if you’re chowing it down with food or not. And the stuff comes in bottles, with each holding 30 tablets.
Reviews
There are no reviews yet.